Summarized by Masters of Longevity from PR Newswire.
Non-invasive wearable neuromodulation after ablation: a news article previewing randomized pilot trial results and implications for post-procedure rhythm care.
Key Takeaways
- The NeuroPulse pilot randomized 77 patients to active median nerve stimulation or sham following AF ablation and continued therapy for six months.
- Post-blanking analysis showed 12 recurrent atrial arrhythmia events with active stimulation versus 28 with sham, a statistically significant difference.
- Freedom from atrial arrhythmias at six months was 90.0% with active stimulation versus 80.8% with sham, but that difference lacked statistical significance.
